Publications by authors named "Mark Brunswick"

Claim this Profile
O
Olgotrelvir as a Single-Agent Treatment of Nonhospitalized Patients with Covid-19.
Rongmeng Jiang, Bing Han, Wanhong Xu, Xiaoying Zhang, Chunxian Peng, Mark Brunswick

NEJM Evid· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olgotrelvir, a dual inhibitor of SARS-CoV-2 M and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19.
Long Mao, Namir Shaabani, Xiaoying Zhang, Can Jin, Wanhong Xu, Mark Brunswick

Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olgotrelvir, a dual inhibitor of SARS-CoV-2 M and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19.
Long Mao, Namir Shaabani, Xiaoying Zhang, Can Jin, Wanhong Xu, Mark Brunswick

Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unbiased approach to identify and assess efficacy of human SARS-CoV-2 neutralizing antibodies.
Xia Cao, Junki Maruyama, Heyue Zhou, Yanwen Fu, Lisa Kerwin, Mark Brunswick

Sci Rep· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel decoy cellular vaccine strategy utilizing transgenic antigen-expressing cells as immune presenter and adjuvant in vaccine prototype against SARS-CoV-2 virus.
Henry Ji, Ying Yan, Beibei Ding, Wenzhong Guo, Mark Brunswick

Med Drug Discov· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proliferative assays for B cell function.
James J Mond, Mark Brunswick

Curr Protoc Immunol· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis